Teligene is a China-based biotechnology company that develops and commercializes small molecule drugs for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 0-0
Address: 218 Xinghu St., A4-416
City: Jiangsu
State: jiangsu province
Zip: 215123
Country: CN
Teligene is a China-based biotechnology company that develops and commercializes small molecule drugs for the treatment of cancer.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2021 | Series C | 1 | $92.9M |
ShenZhen GTJA Investment Group ShenZhen GTJA Investment Group |
2/2021 | Pre-IPO | $93M |
GTJA Investment Group |
8/2018 | Series B | - |
CCB Capital IDG Capital Loyal Valley Capital Shenzhen Capital Group ShenZhen GTJA Investment Group CCB Capital IDG Capital Loyal Valley Capital Shenzhen Capital Group ShenZhen GTJA Investment Group |
8/2018 | Series B | 5 | - |
CCB Capital IDG Capital Loyal Valley Capital Shenzhen Capital Group ShenZhen GTJA Investment Group CCB Capital IDG Capital Loyal Valley Capital Shenzhen Capital Group ShenZhen GTJA Investment Group |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|